{
    "nct_id": "NCT00766363",
    "title": "A Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Phase 1b Safety Study of Three Different Doses of an Alpha-7 Nicotinic Acetylcholine Receptor Agonist (EVP-6124) or Placebo in Patients With Mild to Moderate Probable Alzheimer's Disease",
    "status": "COMPLETED",
    "last_update_time": "2012-04-18",
    "description_brief": "This study is being conducted to determine the safety, tolerability, and pharmacokinetics (PK) of three different doses of an investigational medication, EVP-6124, in individuals with mild to moderate Alzheimer's disease who are also taking an Alzheimer's medication (AChEI \\[acetylcholinesterase inhibitor\\]: either donepezil or rivastigmine). In addition, PK of AChEI medications will be assessed. Cognitive function will be evaluated on an exploratory basis.",
    "description_detailed": "This is a randomized, double-blind, placebo-controlled, Phase 1b safety study of three dose levels of EVP-6124 in subjects with mild or moderate Alzheimer's disease and who are taking an AChEI medication (donepezil or rivastigmine).\n\nStudy drug will be supplied as capsules and will be orally administered once daily for a total of 28 days. Eligible subjects will be admitted to an inpatient study unit on Day -2 (two days before the first dose of study drug is administered) and will remain confined to the inpatient study unit for a total of five days. Starting on Day 4, subjects will continue the study in the outpatient setting, with study visits on Days 7, 14, 21, and 28. Safety assessments, PK sampling, and cognitive testing will be performed inpatient and at each study visit.",
    "phase": [
        "PHASE1"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "preAssignmentDetails": "61 subjects were screened and 49 subjects were enrolled.",
            "recruitmentDetails": "The recruitment period was from September 2008 to February 2009 at 4 study centers in the US (CA, FL, and 2 in NJ).",
            "groups": [
                {
                    "id": "FG000",
                    "title": "EVP-6124 (0.1 mg/Day)",
                    "description": "1 capsule per day for 28 days."
                },
                {
                    "id": "FG001",
                    "title": "EVP-6124 (0.3 mg/Day)",
                    "description": "1 capsule per day for 28 days."
                },
                {
                    "id": "FG002",
                    "title": "EVP-6124 (1.0 mg/Day)",
                    "description": "1 capsule per day for 28 days."
                },
                {
                    "id": "FG003",
                    "title": "Placebo",
                    "description": "1 capsule per day for 28 days."
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "12"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "13"
                                },
                                {
                                    "groupId": "FG002",
                                    "comment": "Number randomized.",
                                    "numSubjects": "12"
                                },
                                {
                                    "groupId": "FG003",
                                    "comment": "Number randomized.",
                                    "numSubjects": "12"
                                }
                            ]
                        },
                        {
                            "type": "SAFETY POPULATION",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "12"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "13"
                                },
                                {
                                    "groupId": "FG002",
                                    "comment": "Decreased by one subject who took placebo instead due to treatment assignment error.",
                                    "numSubjects": "11"
                                },
                                {
                                    "groupId": "FG003",
                                    "comment": "Increased by one subject who took placebo due to treatment assignment error.",
                                    "numSubjects": "13"
                                }
                            ]
                        },
                        {
                            "type": "PK POPULATION",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "12"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "13"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "10"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "13"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "11"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "12"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "12"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "12"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Adverse Event Prior to Randomization",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "EVP-6124 (0.1 mg/Day)",
                    "description": "1 capsule per day for 28 days."
                },
                {
                    "id": "BG001",
                    "title": "EVP-6124 (0.3 mg/Day)",
                    "description": "1 capsule per day for 28 days."
                },
                {
                    "id": "BG002",
                    "title": "EVP-6124 (1.0 mg/Day)",
                    "description": "1 capsule per day for 28 days."
                },
                {
                    "id": "BG003",
                    "title": "Placebo",
                    "description": "1 capsule per day for 28 days."
                },
                {
                    "id": "BG004",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "12"
                        },
                        {
                            "groupId": "BG001",
                            "value": "13"
                        },
                        {
                            "groupId": "BG002",
                            "value": "11"
                        },
                        {
                            "groupId": "BG003",
                            "value": "13"
                        },
                        {
                            "groupId": "BG004",
                            "value": "49"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Categorical",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "<=18 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Between 18 and 65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "18"
                                        }
                                    ]
                                },
                                {
                                    "title": ">=65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "9"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "31"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Age Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "68.6",
                                            "spread": "8.5"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "68.3",
                                            "spread": "11.1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "70.2",
                                            "spread": "12.3"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "72.0",
                                            "spread": "10.5"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "69.8",
                                            "spread": "10.4"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "29"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "20"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "11"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "49"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Safety and Tolerability of Multiple Doses of EVP-6124 or Placebo in Subjects With Alzheimer's Disease",
                    "description": "All adverse experiences spontaneously reported by subject and/or observed by investigator and repeated clinical evaluation of physical examinations, vital signs, 12-lead ECG (electrocardiogram), ambulatory ECG, and laboratory tests (hematology/blood chemistry/urinalysis)",
                    "populationDescription": "Safety Population: All randomized subjects who ingested at least 1 dose of study drug.",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Pre-treatment (Day -2) [or screening for physical examination] to Day 28 [or Day 35, for AEs only]",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EVP-6124 (0.1 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG001",
                            "title": "EVP-6124 (0.3 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG002",
                            "title": "EVP-6124 (1.0 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG003",
                            "title": "Placebo",
                            "description": "1 capsule per day for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "12"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "13"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "11"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "13"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Serious Adverse Events",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Non-Serious Adverse Events",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "4"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "No Adverse Events Reported",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "7"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "9"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "EVP-6124 PK Data Following the First Dose of EVP-6124 - Maximum Concentration (Cmax)",
                    "description": "EVP-6124 PK data; Maximum Concentration (Cmax); i.e, highest concentration of drug in plasma",
                    "populationDescription": "PK Population: All safety population subjects who had sufficient plasma concentration data to facilitate calculation of PK parameters.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ng/mL",
                    "timeFrame": "24 hours",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EVP-6124 (0.1 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG001",
                            "title": "EVP-6124 (0.3 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG002",
                            "title": "EVP-6124 (1.0 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "12"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "13"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.0715",
                                            "spread": "0.0121"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.1911",
                                            "spread": "0.0740"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.6122",
                                            "spread": "0.1235"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "EVP-6124 PK Data Following the First Dose of EVP-6124 - Time to Maximum Concentration (Tmax)",
                    "description": "EVP-6124 PK data; Time to Maximum Concentration (Tmax); i.e, amount of time required to reach highest concentration of drug in plasma",
                    "populationDescription": "PK Population: All safety population subjects who had sufficient plasma concentration data to facilitate calculation of PK parameters.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "hours",
                    "timeFrame": "24 hours",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EVP-6124 (0.1 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG001",
                            "title": "EVP-6124 (0.3 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG002",
                            "title": "EVP-6124 (1.0 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "12"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "13"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "7.70",
                                            "spread": "3.31"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "7.94",
                                            "spread": "3.61"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "10.72",
                                            "spread": "6.69"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "EVP-6124 PK Data Following the First Dose of EVP-6124 - Area Under the Curve (AUC[0-24 h])",
                    "description": "EVP-6124 PK data; Area Under the Curve (AUC\\[0-24 h\\]); i.e, area under the concentration-time plot",
                    "populationDescription": "PK Population: All safety population subjects who had sufficient plasma concentration data to facilitate calculation of PK parameters.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "h*ng/mL",
                    "timeFrame": "24 hours",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EVP-6124 (0.1 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG001",
                            "title": "EVP-6124 (0.3 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG002",
                            "title": "EVP-6124 (1.0 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "12"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "11"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "7"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.31",
                                            "spread": "0.23"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3.89",
                                            "spread": "0.84"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "11.44",
                                            "spread": "2.24"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Donepezil PK Data Following the First Dose of EVP-6124 - Maximum Concentration (Cmax)",
                    "description": "Donepezil PK data; Maximum Concentration (Cmax); i.e, highest concentration of donepezil (parent compound only) in plasma after dosing with EVP-6124",
                    "populationDescription": "PK Population: All safety population subjects who had sufficient plasma concentration data to facilitate calculation of PK parameters.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ng/mL",
                    "timeFrame": "24 hours",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EVP-6124 (0.1 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG001",
                            "title": "EVP-6124 (0.3 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG002",
                            "title": "EVP-6124 (1.0 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG003",
                            "title": "Placebo",
                            "description": "1 capsule per day for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "13"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "7"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "13"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "29.5",
                                            "spread": "15.8"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "24.7",
                                            "spread": "19.8"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "39.2",
                                            "spread": "26.7"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "41.9",
                                            "spread": "19.7"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Donepezil PK Data Following the First Dose of EVP-6124 - Time to Maximum Concentration (Tmax)",
                    "description": "Donepezil PK data; Time to Maximum Concentration (Tmax); i.e, amount of time required to reach highest concentration of donepezil (parent compound only) in plasma after dosing with EVP-6124",
                    "populationDescription": "PK Population: All safety population subjects who had sufficient plasma concentration data to facilitate calculation of PK parameters.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "hours",
                    "timeFrame": "24 hours",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EVP-6124 (0.1 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG001",
                            "title": "EVP-6124 (0.3 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG002",
                            "title": "EVP-6124 (1.0 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG003",
                            "title": "Placebo",
                            "description": "1 capsule per day for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "12"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "7"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "13"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.30",
                                            "spread": "2.65"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.85",
                                            "spread": "2.15"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "3.31",
                                            "spread": "3.01"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "3.56",
                                            "spread": "4.02"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Donepezil PK Data Following the First Dose of EVP-6124 - Area Under the Curve (AUC[0-24 h])",
                    "description": "Donepezil PK data; Area Under the Curve (AUC\\[0-24 h\\]); i.e, area under the concentration-time plot for donepezil (parent compound only) after dosing with EVP-6124",
                    "populationDescription": "PK Population: All safety population subjects who had sufficient plasma concentration data to facilitate calculation of PK parameters.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "h*ng/mL",
                    "timeFrame": "24 hours",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EVP-6124 (0.1 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG001",
                            "title": "EVP-6124 (0.3 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG002",
                            "title": "EVP-6124 (1.0 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG003",
                            "title": "Placebo",
                            "description": "1 capsule per day for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "13"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "7"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "13"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "299",
                                            "spread": "179"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "240",
                                            "spread": "194"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "345",
                                            "spread": "225"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "427",
                                            "spread": "233"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Rivastigmine PK Data Following the First Dose of EVP-6124 - Maximum Concentration (Cmax)",
                    "description": "Rivastigmine PK data; Maximum Concentration (Cmax); i.e, highest concentration of rivastigmine in plasma after dosing with EVP-6124",
                    "populationDescription": "PK Population: All safety population subjects who had sufficient plasma concentration data to facilitate calculation of PK parameters. Only 4 subjects took rivastigmine concomitantly.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ng/mL",
                    "timeFrame": "24 hours",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EVP-6124 (0.1 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG001",
                            "title": "EVP-6124 (1.0 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "2"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "2"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "23.35",
                                            "spread": "5.16"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3.51",
                                            "spread": "0.37"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Rivastigmine PK Data Following the First Dose of EVP-6124 - Time to Maximum Concentration (Tmax)",
                    "description": "Rivastigmine PK data; Time to Maximum Concentration (Tmax); i.e, amount of time required to reach highest concentration of rivastigmine in plasma after dosing with EVP-6124",
                    "populationDescription": "PK Population: All safety population subjects who had sufficient plasma concentration data to facilitate calculation of PK parameters. Only 4 subjects took rivastigmine concomitantly.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "hours",
                    "timeFrame": "24 hours",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EVP-6124 (0.1 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG001",
                            "title": "EVP-6124 (1.0 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "2"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "2"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.00",
                                            "spread": "0.02"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "12.12",
                                            "spread": "15.72"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Rivastigmine PK Data Following the First Dose of EVP-6124 - Area Under the Curve (AUC[0-24 h])",
                    "description": "Rivastigmine PK data; Area Under the Curve (AUC\\[0-24 h\\]); i.e, area under the concentration-time plot for rivastigmine after dosing with EVP-6124",
                    "populationDescription": "PK Population: All safety population subjects who had sufficient plasma concentration data to facilitate calculation of PK parameters. Only 4 subjects took rivastigmine concomitantly.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "h*ng/mL",
                    "timeFrame": "24 hours",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "EVP-6124 (0.1 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        },
                        {
                            "id": "OG001",
                            "title": "EVP-6124 (1.0 mg/Day)",
                            "description": "1 capsule per day for 28 days."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "2"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "2"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "143.55",
                                            "spread": "85.52"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "54.60",
                                            "spread": "6.28"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "timeFrame": "Adverse events were collected from pre-treatment (Day -2) to 7 days after the last dose of study drug (Day 35).",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "EVP-6124 (0.1 mg/Day)",
                    "description": "1 capsule per day for 28 days.",
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 12,
                    "otherNumAffected": 2,
                    "otherNumAtRisk": 12
                },
                {
                    "id": "EG001",
                    "title": "EVP-6124 (0.3 mg/Day)",
                    "description": "1 capsule per day for 28 days.",
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 13,
                    "otherNumAffected": 3,
                    "otherNumAtRisk": 13
                },
                {
                    "id": "EG002",
                    "title": "EVP-6124 (1.0 mg/Day)",
                    "description": "1 capsule per day for 28 days.",
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 11,
                    "otherNumAffected": 4,
                    "otherNumAtRisk": 11
                },
                {
                    "id": "EG003",
                    "title": "Placebo",
                    "description": "1 capsule per day for 28 days.",
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 13,
                    "otherNumAffected": 4,
                    "otherNumAtRisk": 13
                }
            ],
            "otherEvents": [
                {
                    "term": "Atrial fibrillation",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        }
                    ]
                },
                {
                    "term": "Vision blurred",
                    "organSystem": "Eye disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 13
                        }
                    ]
                },
                {
                    "term": "Constipation",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        }
                    ]
                },
                {
                    "term": "Diarrhoea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        }
                    ]
                },
                {
                    "term": "Flatulence",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        }
                    ]
                },
                {
                    "term": "Nausea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        }
                    ]
                },
                {
                    "term": "Vomiting",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        }
                    ]
                },
                {
                    "term": "Vessel puncture site pain",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        }
                    ]
                },
                {
                    "term": "Upper respiratory tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        }
                    ]
                },
                {
                    "term": "Headache",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 2,
                            "numAffected": 1,
                            "numAtRisk": 13
                        }
                    ]
                },
                {
                    "term": "Somnolence",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 13
                        }
                    ]
                },
                {
                    "term": "Insomnia",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        }
                    ]
                },
                {
                    "term": "Pharyngolaryngeal pain",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 13
                        }
                    ]
                },
                {
                    "term": "Rash erythematous",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        }
                    ]
                },
                {
                    "term": "Hypotension",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA (11.1)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 12
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG003",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 13
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictionType": "OTHER",
                "restrictiveAgreement": true,
                "otherDetails": "The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted for review. At the sponsor's request, the PI will delete confidential information other than trial data and will delay publication or disclosure for up to 90 days to allow patent filings. The PI agrees that the first publication shall be a joint publication."
            },
            "pointOfContact": {
                "title": "Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development",
                "organization": "EnVivo Pharmaceuticals, Inc.",
                "email": "mgawryl@envivopharma.com",
                "phone": "617-225-4264"
            }
        }
    },
    "target_category": "cognitive enhancer",
    "drug": [
        "EVP-6124 (encenicline) \u2014 an \u03b17 nicotinic acetylcholine receptor partial agonist"
    ],
    "placebo": [
        "placebo"
    ],
    "explanation_target": [
        "Reason: The investigational drug EVP-6124 (encenicline) is described in the trial title as an alpha-7 nicotinic acetylcholine receptor agonist and the study measures safety/tolerability/PK with cognitive function assessed exploratorily; this indicates a symptomatic, cognition-focused intervention rather than a disease-modifying biologic. \ue200cite\ue202turn0search1\ue202turn0search8\ue201.",
        "Act: EVP-6124/encenicline is a small-molecule, selective \u03b17 nAChR partial agonist developed to improve cognition in Alzheimer\u2019s disease and schizophrenia (preclinical and clinical data show memory and attention benefits). The trial gives EVP-6124 as adjunct to AChE inhibitors and assesses cognition exploratorily, consistent with a cognitive enhancer indication. \ue200cite\ue202turn0search3\ue202turn0search9\ue201.",
        "Web search results (supporting sources used): PubMed summary describing EVP-6124 as an \u03b17 nAChR partial agonist investigated for symptomatic treatment of AD. \ue200cite\ue202turn0search1\ue201.",
        "Clinical Therapeutics / PubMed papers reporting pharmacodynamics/PK and Phase I/II results for encenicline (EVP-6124) showing cognitive effects and tolerability. \ue200cite\ue202turn0search8\ue202turn0search0\ue201.",
        "Reflect: Because EVP-6124 is a small-molecule receptor agonist aimed at improving cognitive function (not a monoclonal antibody, vaccine, or pathology-targeting enzyme inhibitor), it fits the 'cognitive enhancer' category rather than 'disease-targeted biologic' or 'disease-targeted small molecule'. No substantial evidence in the trial description suggests primary intent to modify AD pathology or to treat neuropsychiatric symptoms specifically. \ue200cite\ue202turn0search3\ue202turn0search9\ue201."
    ],
    "agent_type": "D) Neurotransmitter Receptors",
    "explanation_agent": [
        "Reason: The trial drug EVP-6124 (encenicline) is described explicitly as a selective \u03b17 nicotinic acetylcholine receptor (\u03b17 nAChR) partial agonist and was developed as a symptomatic cognitive enhancer for AD; that indicates the intervention acts on a neurotransmitter receptor. \ue200cite\ue202turn0search4\ue202turn0search0\ue201",
        "Act: Extracted details \u2014 drug: encenicline (EVP-6124); mechanism: selective \u03b17 nicotinic acetylcholine receptor partial agonist; indication in trials: cognition/cognitive enhancement in mild\u2013moderate AD often given adjunctive to AChE inhibitors; trial stage here: Phase 1b safety/PK with exploratory cognitive assessment. These facts map to the CADRO category for neurotransmitter receptors. \ue200cite\ue202turn0search5\ue202turn0search8\ue201",
        "Reflect: Classification check \u2014 \u03b17 nAChR is a neuronal neurotransmitter receptor (cholinergic receptor family), so the most specific CADRO category is D) Neurotransmitter Receptors. There is no indication this compound is targeting amyloid, tau, inflammation, vasculature, or other disease-modifying pathways in the provided description. Therefore D is the correct assignment. \ue200cite\ue202turn0search4\ue202turn0search8\ue201",
        "Web search results (supporting sources):",
        "- Encenicline (EVP-6124) characterized as an \u03b17 nAChR partial agonist with pro-cognitive effects (Neuropharmacology / preclinical characterization). \ue200cite\ue202turn0search4\ue201",
        "- Pharmacodynamics, pharmacokinetics, safety and tolerability studies of encenicline in single ascending-dose studies showing procognitive PD effects and PK data. \ue200cite\ue202turn0search0\ue201",
        "- Safety and clinical effects in subjects with AD (Phase I/II summary; encenicline investigated as symptomatic cognitive treatment). \ue200cite\ue202turn0search5\ue201",
        "- ALZforum summary of Phase 2 results and development context describing EVP-6124 as an adjunctive cognitive-enhancing \u03b17 nAChR partial agonist in AD trials. \ue200cite\ue202turn0search8\ue201"
    ]
}